Shortage Of Antimicrobial Agents Used In Tuberculosis (Tb) Treatment
Posted on:
The following antimicrobial medicines used to treat
tuberculosis (TB) will be intermittently available until at least the end of
2025:
- Rifampicin 150mg and 300mg
capsules
- Rifampicin 600mg IV
solution for infusion
- Rifampicin 100mg/5ml oral suspension
- Rifinah® 300
tablets (rifampicin 300mg / isoniazid 150mg)
- Rifater®
tablets (rifampicin 120mg / isoniazid 50mg/ pyrazinamide 300mg)
- Voractiv®
tablets (rifampicin 150mg/ isoniazid 75mg / pyrazinamide 400mg / ethambutol
275mg)
- Pyrazinamide 500mg tablets
Ethambutol tablets, Isoniazid tablets, and Rifinah® 150 tablets (rifampicin 150?mg / isoniazid 100?mg) and Mycobutin® (rifabutin) 150mg capsules remain available but cannot support a full increase in demand.
This National Patient Safety Alert provides further background, clinical information and actions for providers.